Výsledky vyhľadávania - "Lindqvist, Anton"

  • Zobrazené výsledky 1 - 6 z 6
Upresniť hľadanie
  1. 1

    Efficient protein production inspired by how spiders make silk Autor Kronqvist, Nina, Sarr, Médoune, Lindqvist, Anton, Nordling, Kerstin, Otikovs, Martins, Venturi, Luca, Pioselli, Barbara, Purhonen, Pasi, Landreh, Michael, Biverstål, Henrik, Toleikis, Zigmantas, Sjöberg, Lisa, Robinson, Carol V., Pelizzi, Nicola, Jörnvall, Hans, Hebert, Hans, Jaudzems, Kristaps, Curstedt, Tore, Rising, Anna, Johansson, Jan

    ISSN: 2041-1723, 2041-1723
    Vydavateľské údaje: London Nature Publishing Group UK 23.05.2017
    Vydané v Nature communications (23.05.2017)
    “…Membrane proteins are targets of most available pharmaceuticals, but they are difficult to produce recombinantly, like many other aggregation-prone proteins…”
    Získať plný text
    Journal Article
  2. 2

    Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol Autor Ludvigsson, Johnny, Eriksson, Linnea, Nowak, Christoph, Teixeira, Pedro F, Widman, Martina, Lindqvist, Anton, Casas, Rosaura, Lind, Marcus, Hannelius, Ulf

    ISSN: 2044-6055, 2044-6055
    Vydavateľské údaje: London British Medical Journal Publishing Group 31.10.2022
    Vydané v BMJ OPEN (31.10.2022)
    “…IntroductionType 1 diabetes (T1D) is an autoimmune disease leading to the destruction of the insulin-producing beta cells resulting in insulin deficiency and…”
    Získať plný text
    Journal Article Publikácia
  3. 3

    Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial Autor Casas, Rosaura, Tompa, Andrea, Åkesson, Karin, Teixeira, Pedro F., Lindqvist, Anton, Ludvigsson, Johnny

    ISSN: 1422-0067, 1661-6596, 1422-0067
    Vydavateľské údaje: Switzerland MDPI AG 01.01.2025
    “…Immunotherapies aimed at preserving residual beta cell function in type 1 diabetes have been successful, although the effect has been limited, or raised safety…”
    Získať plný text
    Journal Article
  4. 4

    Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data Autor Teixeira, Pedro F., Battelino, Tadej, Carlsson, Anneli, Gudbjörnsdottir, Soffia, Hannelius, Ulf, von Herrath, Matthias, Knip, Mikael, Korsgren, Olle, Elding Larsson, Helena, Lindqvist, Anton, Ludvigsson, Johnny, Lundgren, Markus, Nowak, Christoph, Pettersson, Paul, Pociot, Flemming, Sundberg, Frida, Åkesson, Karin, Lernmark, Åke, Forsander, Gun

    ISSN: 0012-186X, 1432-0428, 1432-0428
    Vydavateľské údaje: Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2024
    Vydané v Diabetologia (01.06.2024)
    “…The type 1 diabetes community is coalescing around the benefits and advantages of early screening for disease risk. To be accepted by healthcare providers,…”
    Získať plný text
    Journal Article
  5. 5

    C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis Autor Taylor, Peter N, Collins, Kimberly S, Lam, Anna, Karpen, Stephen R, Greeno, Brianna, Walker, Frank, Lozano, Alejandro, Atabakhsh, Elnaz, Ahmed, Simi T, Marinac, Marjana, Latres, Esther, Senior, Peter A, Rigby, Mark, Gottlieb, Peter A, Dayan, Colin M

    ISSN: 2213-8595, 2213-8595
    Vydavateľské údaje: England 01.12.2023
    Vydané v The lancet. Diabetes & endocrinology (01.12.2023)
    “…Metabolic outcomes in type 1 diabetes remain suboptimal. Disease modifying therapy to prevent β-cell loss presents an alternative treatment framework but the…”
    Zistit podrobnosti o prístupe
    Journal Article
  6. 6

    Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli Autor Sandegren, Linus, Lindqvist, Anton, Kahlmeter, Gunnar, Andersson, Dan I

    ISSN: 1460-2091, 1460-2091
    Vydavateľské údaje: England 01.09.2008
    Vydané v Journal of antimicrobial chemotherapy (01.09.2008)
    “…The biological fitness cost of antibiotic resistance is a key parameter in determining the rate of appearance and spread of antibiotic-resistant bacteria. We…”
    Zistit podrobnosti o prístupe
    Journal Article